This domain may be for sale!
Location: United States, North Carolina, Pittsboro
Employees: 11-50
Total raised: $30M
Investors 2
| Date | Name | Website |
| - | The Trelys... | trelys.com |
| - | Tall Oaks ... | talloaksca... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.05.2007 | - | $30M | - |
Mentions in press and media 5
| Date | Title | Description |
| 06.10.2008 | Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C | - |
| 07.02.2008 | IPO roundup: Is the window slamming on life sciences? | It’s sure starting to look that way. News that Archemix, a Cambridge, Mass., developer of aptamer-based drugs, yesterday withdrew its $72.5 million IPO follows closely on the heels of several other recent several other IPO collapses, includ... |
| 04.02.2008 | Life sciences briefing: Monday, Feb. 4, 2008 | TODAY’S HEADLINES: PEAK Surgical takes in $21M for electrosurgical tools (release) CellGate acquired by Australian cancer biotech ProGen for $2.5M (release) Traversa raises $2M for RNAi-delivery technologies (release) RemitDATA, Web-based h... |
| 14.08.2007 | Life sciences briefing: Tuesday, Aug. 14, 2007 | Featured companies: Tenaxis Medical, Aspen MedTech, Biolex Therapeutics Tenaxis closes up $5M for surgical sealants — Mountain View, Calif.-based Tenaxis Medical, a developer of glues and sealants for closing surgical incisions, raised $5 m... |
| 29.05.2007 | Biolex Therapeutics raises $30M for multiple-sclerosis treatment | Biolex Therapeutics, a Pittsboro, N.C., developer of technology for improving the properties of monoclonal antibodies, raised $30 million in a third funding round. Biolex specializes in producing proteins that are difficult to make with exi... |